MarketPeel
Insider Trading Intelligence
WT

William D. Turner

VERA
CHIEF REGULATORY OFFICER · VERA THERAPEUTICS, INC. · CIK 0001819688
FILING MIX · LIFETIME53%/47%
BUYS
8
SELLS
7
TOTAL VALUE
$1.91M
COMPANIES
1
ACTIVE SINCE
Jan 2024
HOLDINGS NOW
45,313
AVG SELL PX
$44.91
TRADE KIND
SHOWING 15 / 15
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
4 backtested trades · 8 horizons · 9 pending
Forward-return performance of every backtestable P/S trade by William D. Turner, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d4+25.00%+5.53%+0.33%+5.21%+7.81%
14d4+25.00%+8.97%-0.30%+9.27%+12.19%
30d4+50.00%+4.95%-0.39%+5.34%+3.23%
60d4+75.00%-4.56%+1.87%-6.43%-9.39%
90d4+100.00%-13.97%-1.01%-11.27%-12.67%
180d4(1 pending)+100.00%-25.81%+8.42%-40.18%-40.18%
1y4(4 pending)
2y4(4 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
VERA · 45,313 shares · as of Feb 23, 2026
068,750137,500206,250275,00020252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 8 buys / 7 sellsCOVERAGE · 9 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
VERA
VERA THERAPEUTICS, INC.
SALE
Chief Regulatory Officer
2,187$41.98$91.8K45,313Feb 23, 2026Feb 25, 2026View →
VERA
VERA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
25,00047,500Feb 4, 2026Feb 6, 2026View →
VERA
VERA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
50,00050,000Feb 4, 2026Feb 6, 2026View →
VERA
VERA THERAPEUTICS, INC.
SALE
Chief Regulatory Officer
10,000245,000Dec 15, 2025Dec 17, 2025View →
VERA
VERA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
10,000$50.08$500.8K22,500Dec 15, 2025Dec 17, 2025View →
VERA
VERA THERAPEUTICS, INC.
PURCHASE
Chief Regulatory Officer
10,000$15.53$155.3K32,500Dec 15, 2025Dec 17, 2025View →
VERA
VERA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
10,000$45.31$453.1K22,500Dec 8, 2025Dec 10, 2025View →
VERA
VERA THERAPEUTICS, INC.
PURCHASE
Chief Regulatory Officer
10,000$15.53$155.3K32,500Dec 8, 2025Dec 10, 2025View →
VERA
VERA THERAPEUTICS, INC.
SALE
Chief Regulatory Officer
10,000255,000Dec 8, 2025Dec 10, 2025View →
VERA
VERA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
10,000$40.00$400.0K22,500Dec 3, 2025Dec 4, 2025View →
VERA
VERA THERAPEUTICS, INC.
SALE
Chief Regulatory Officer
10,000265,000Dec 3, 2025Dec 4, 2025View →
VERA
VERA THERAPEUTICS, INC.
PURCHASE
Chief Regulatory Officer
10,000$15.53$155.3K32,500Dec 3, 2025Dec 4, 2025View →
VERA
VERA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
22,50022,500Feb 18, 2025Feb 20, 2025View →
VERA
VERA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
45,00045,000Feb 18, 2025Feb 20, 2025View →
VERA
VERA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
275,000275,000Jan 5, 2024Jan 9, 2024View →
Other insiders · VERA
Loading peer insiders…
About this filer
CIK 0001819688
ROLE
Chief Regulatory Officer
PRIMARY
VERA
COMPANIES
1
ACTIVE SINCE
Jan 2024
MARKETPEEL · /INSIDER/0001819688DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback